JP Morgan Upgrades EPR Props to Neutral, Announces $52 Price Target
JP Morgan analyst Anthony Paolone upgrades EPR Props (NYSE:EPR) from Underweight to Neutral and announces $52 price target.
JP Morgan Upgrades Regency Centers to Overweight, Raises Price Target to $72
JP Morgan analyst Michael Mueller upgrades Regency Centers (NASDAQ:REG) from Neutral to Overweight and raises the price target from $70 to $72.
JP Morgan Upgrades First Industrial Realty to Overweight, Raises Price Target to $56
JP Morgan analyst Michael Mueller upgrades First Industrial Realty (NYSE:FR) from Neutral to Overweight and raises the price target from $53 to $56.
JP Morgan Upgrades Meta Platforms to Overweight, Raises Price Target to $150
JP Morgan analyst Doug Anmuth upgrades Meta Platforms (NASDAQ:META) from Neutral to Overweight and raises the price target from $115 to $150.
Goldman Sachs Upgrades Immunocore Hldgs to Buy
Goldman Sachs analyst Rajan Sharma upgrades Immunocore Hldgs (NASDAQ:IMCR) from Neutral to Buy.
BioNTech Stock Gets Upgrade, Analyst Sees Multiple Upside Opportunities
BofA Securities has upgraded BioNTech SE (NASDAQ:BNTX) and maintains a $239 price target. The analyst views the current valuation as an attractive…
Why This Verizon Communications Analyst Is Turning Bullish
Shares of Verizon Communications Inc. (NYSE: VZ) Thursday reversed a downward trend in place since the beginning of this week.
B of A Securities Upgrades Radian Group to Buy, Announces $24 Price Target
B of A Securities analyst Mihir Bhatia upgrades Radian Group (NYSE:RDN) from Neutral to Buy and announces $24 price target.
Morgan Stanley Upgrades Madison Square Garden to Equal-Weight, Announces $50 Price Target
Morgan Stanley analyst Benjamin Swinburne upgrades Madison Square Garden (NYSE:MSGE) from Underweight to Equal-Weight and announces $50 price target.
Barclays Upgrades Wyndham Hotels & Resorts to Overweight, Raises Price Target to $88
Barclays analyst Brandt Montour upgrades Wyndham Hotels & Resorts (NYSE:WH) from Equal-Weight to Overweight and raises the price target from $80 to $88.